A spatiotemporal analysis of public pharmaceutical expenditure

Annals of Regional Science

Volumn 44, Issue 2, 2010, Pages 299-314

  Lauridsen, Jorgen ^a   Bech, Mickael ^a,b   López, Fernando ^c   Sánchez, Mariluz Maté ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c TECHNICAL UNIVERSITY OF CARTAGENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCORRELATION; HEALTH EXPENDITURE; PHARMACEUTICAL INDUSTRY; REGRESSION ANALYSIS; SPATIOTEMPORAL ANALYSIS;

SPAIN;

EID: 77953798229     PISSN: 05701864     EISSN: 14320592     Source Type: Journal    
DOI: 10.1007/s00168-008-0259-2     Document Type: Article

References (40)

1. Anselin L (1988) Spatial econometrics: methods and models. Kluwer, North-Holland.
2. Antoñanzas F, Oliva J, Pinillos M, Juárez C (2007) European aspects of the new Spanish laws on pharmaceutical preparations. Eur J Health Econ 8: 297-300.
3. Bech M, Lauridsen J, Lopez F, Sánchez MM (2006) Dynamic patterns and small-area variation in public pharmaceutical expenditure. Working paper, Department of Business and Economics. University of Southern Denmark, Denmark.
4. Brueckner JK (2003) Strategic interaction among governments: an overview of empirical studies. Int Reg Sci Rev 26: 175-188.
5. Case AC, Rosen HS, Hines JR (1993) Budget spillovers and fiscal-policy interdependence-evidence from the States. J Public Econ 52: 285-307.
6. Costa-Font J, Puig-Junoy J (2004) Regulatory ambivalence and the limitations of pharmaceutical policy in Spain. Working paper no. 762, Faculty of Economics and Business, Universitat Pompeu Fabra.
7. Costa-Font J, Pons-Novell J (2007) Public health expenditure and spatial interactions in a decentralized national health system. Health Econ 16: 291-306.
8. Costa-Font J, Moscone F (2008) The impact of descentralization and inter territorial interactions of Spanish health expenditure. Empir Econ 34: 167-184.
9. Darbá J (2003a) Pharmaceutical expenditure and therapeutic value of new medicines in Spain. Pharmacoeconomics 21: 1211-1212.
10. Darbá J (2003b) Pharmaceutical expenditure in Spain: evolution and cost containment measures during 1998-2001. Eur J Health Econ 4: 151-157.
11. Dubois RW, Batchlor E, Wade S (2002) Geographic variation in the use of medications: Is uniformity good news or bad? Health Affairs 21: 240-250.
12. Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S (2000) Explaining drug spending trends: Does perception match reality? Health Affairs 19: 231-239.
13. Ess SM, Schneeweiss S, Szucs TD (2003) European healthcare policies for controlling drug expenditure. Pharmacoeconomics 21: 89-103.
14. Florax RJGM (1992) The University: A regional booster? Economic impacts of academic knowledge infrastructure. Aldershot, Avebury.
15. Folland S, Goodman AC, Stano M (2003) The economics of health and health care. Prentice Hall, Upper Saddle River.
16. Gerdtham UG, Lundin D (2004) Why did drug spending increase during the 1990s? A decomposition based on Swedish data. Pharmacoeconomics 22: 29-42.
17. Griffith D (1996) Spatial autocorrelation and eigenfunctions of the geographic weights matrix accompanying geo-referenced data. Can Geogr 40: 351-367.
18. Griffith D (2000) A linear regression solution to the spatial autocorrelation problem. J Geogr Syst 2: 141-156.
19. Griffith D (2003) Spatial autocorrelation and spatial filtering. Springer, Berlin.
20. Ham C (1988) Health care variation: assessing the evidence. Working paper. King's Fund Institute, London.
21. Henrekson M (1988) Swedish government growth: a disequilibrium analysis. In: Lybeck JA, Henrekson M (eds) Explaining the growth of government. North-Holland, Amsterdam.
22. Joines JD, Hertz-Picciotto I, Carey TS, Gesler W, Suchindran C (2003) A spatial analysis of county-level variation in hospitalization rates for low back problems in North Carolina. Soc Sci Med 56: 2541-2553.
23. Kitchener M, Carrillo H, Harrington C (2003) Medicaid community-based programs: a longitudinal analysis of state variation in expenditures and utilization. Inquiry 4: 375-389.
24. Levaggi R, Zanola R (2003) Flypaper effect and sluggishness: evidence from regional health expenditure in Italy. Int Tax Public Fin 10: 535-547.
25. Lopez-Casasnovas G (2005) Economic considerations regarding pharmaceutical expenditure in Spain and its financing. In: Puig-Junoy J (ed) The public financing of pharmaceuticals: an economic approach. Edward Elgar, Cheltenham, pp 189-209.
26. Lopez-Casasnovas G, Saez M (2001) A multilevel analysis on the determinants of regional health care expenditure. A note. Economics Working Paper 572, Research Centre on Health and Economics (CRES).
27. Lopez-Casasnovas G, Costa-Font J, Planas I (2005) Diversity and regional inequalities in the Spanish system of health care services. Health Econ 14: S221-S235.
28. Metge C, Black C, Peterson S, Kozyrskyj AL (1999) The population's use of pharmaceuticals. Med Care 37: JS42-JS59.
29. Morgan SG (2005) Booming prescription drug expenditure-a population-based analysis of age dynamics. Med Care 43: 996-1008.
30. Moscone F, Knapp M (2005) Exploring the spatial pattern of mental health expenditure. J Mental Health Policy Econ 8: 205-217.
31. Puig-Junoy J (2004) Incentives and pharmaceutical reimbursement reforms in Spain. Health Policy 67: 149-165.
32. Revelli F (2002) Testing the tax mimicking versus expenditure spill-over hypotheses using English data. Appl Econ 34: 1723-1731.
33. Revelli F (2005) On spatial public finance empirics. Int Tax Public Fin 12: 475-492.
34. Revelli F (2006) Performance rating and yardstick competition in social service provision. J Public Econ 90: 459-475.
35. Rovira J, Tremosa R, Gilabert A, Torralba M (2001) The role of prices in drug expenditure analysis. Health Econ Prevent and Care 2: 142-149.
36. Tavares J (2004) Does the right or leftmatter? Cabinets, credibility and adjustments. J Public Econ 88: 2447-2468.
37. Tiefelsdorf M, Boots B (1995) The exact distribution of Moran's I. Environ Plann A 27: 985-999.
38. Wennberg J, Gittelsohn A (1973) Small area variation in health-care delivery. Science 182: 1102-1107.
39. Westert GP, Groenewegen PP, Boshuizen HC, Spreeuwenberg PMM, Steultjens MPM (2004) Medical practice variations in hospital care; time trends of a spatial phenomenon. Health Place 10: 215-220.
40. Zellner A (1962) An efficient method of estimating seemingly unrelated regressions and tests of aggregation bias. J Am Stat Assoc 57: 348-368.